NCT07656545

Brief Summary

The purpose of this clinical trial is to adapt and test a brief patient-caregiver early intervention designed to reduce posttraumatic stress symptoms in hospitalized burn patients and their caregivers. This intervention is a brief, 4-session cognitive-behavioral intervention designed for burn patients and their loved one to complete together, during and after hospitalization. The intervention targets relational communication and functioning through reduction of invalidating, negative statements and avoidant coping by teaching patients and their loved ones to engage in adaptive natural disclosures, supportive responses, and approach coping after the burn trauma. The intervention uses evidence-based psychotherapy techniques, including psychoeducation, motivational interviewing, and skills coaching. The clinical trial will occur in two sequential phases. In the first phase of the study (case series), the intervention will be provided to two burn patient-caregiver dyads (four adults) to pilot test the intervention, seek patient and provider feedback, and refine the intervention. All four adults will receive the intervention. In the second phase of the study, the randomized controlled trial (RCT) phase, investigators will enroll 20 more burn patient-caregiver dyads (40 more adults) who will be randomly assigned (like the flip of a coin) at the dyad level to receive the intervention or a burn survivor-only minimally enhanced usual care psychoeducation control condition (mEUC). The goals of the RCT phase are to study whether the intervention is acceptable to patients, feasible to conduct, and whether the intervention improves burn survivor-caregiver healthy relationship communication about difficult events and treatment outcomes compared to mEUC.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
31mo left

Started Aug 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 3, 2026

Completed
15 days until next milestone

First Posted

Study publicly available on registry

June 18, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

August 1, 2026

Expected
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2028

2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2029

Last Updated

June 18, 2026

Status Verified

June 1, 2026

Enrollment Period

2.4 years

First QC Date

June 3, 2026

Last Update Submit

June 14, 2026

Conditions

Outcome Measures

Primary Outcomes (6)

  • Social Constraints Scale

    The Social Constraints Scale is a self-report scale administered to both the patient and caregiver. It is designed to assess perceptions of negative reactions to trauma-disclosures. The scale contains 15 items, and each item is scored on a four-point scale ranging from 1 (never) to 4 (often) with total scores ranging from 15 to 60. A higher score indicates a higher frequency of experiencing social constraints.

    Before treatment, immediately after ending treatment, 6-week follow-up

  • Feasibility of Recruitment

    Proportion of participants who agree to participate from the total number of those that are eligible and approached.

    baseline

  • Feasibility of Data Collection

    Proportion of participants who completed each and all assessment timepoints

    From enrollment to the end of study assessments at 6-weeks posttreament

  • Acceptability: Satisfaction with Treatment

    Client Satisfaction Questionnaire (CSQ) - Self-Report - The CSQ has 8 items assessing client satisfaction with the treatment they have received. Total scores range from 8-32; higher scores indicate greater client satisfaction/treatment acceptability. This measure will be completed by both patients and their loved ones.

    Immediately after ending treatment

  • Acceptabilitly: Retention

    Proportion of enrolled dyads who completed at least 3 out of 4 PoED sessions.

    Immediately after ending treatment

  • Acceptability: Global Improvement Rating

    Proportion of participants who report overall improvement on the Global Rating of Change Scale

    Immediately after ending treatment

Secondary Outcomes (6)

  • PTSD Checklist for DSM-5 (PCL-5)

    Pretreatment, Immediately after ending treatment, 6-week follow-up

  • Clinician-Administered PTSD Scale for DSM-5 (CAPS-5)

    Immediately after ending treatment, 6-week follow-up

  • Hospital Anxiety and Depression Scale (HADS)

    Pretreatment, immediately after ending treatment, 6-week follow-up

  • MINI Montreal International Neuropsychiatric Interview v. 7.0.2 (MINI)

    Pretreatment, immediately after ending treatment, 6-week follow-up

  • Dyadic Relationship Scale (DRS)

    Pretreatment, immediately after ending treatment, 6-week follow-up

  • +1 more secondary outcomes

Study Arms (2)

Promotion of Emotional Disclosure for Burns (PoED-B)

EXPERIMENTAL

Participants randomized into this arm will receive Promotion of Emotional Disclosure for Burns (PoED-B), a cognitive behavioral therapy intervention designed for burn survivors and a loved one of their choosing to complete together. The standard treatment length will be 4 sessions, however participants and providers may agree to additional sessions as warranted.

Behavioral: Promotion of Emotional Disclosure for Burns (PoED-B)

minimally Enhanced Usual Care control (mEUC)

ACTIVE COMPARATOR

Participants randomized into this arm will receive a minimally enhanced version of usual burn care. This will include one, 30-minute supportive therapy session focused on psychoeducation about the potential psychological impact of burn injury and hospitalization and referral to outpatient resources, if wanted.

Behavioral: minimally Enhanced Usual Care control (mEUC)

Interventions

PoED-B is a dyadic treatment where both patient and identified informal caregiver participate. PoED-B targets reducing disclosure-constraining behaviors (e.g., invalidating, negative statements) using psychoeducation, motivational interviewing, and skills training. The goal is to encourage the patient-caregiver dyad to engage in natural disclosures, supportive responses, and approach coping after the burn trauma to facilitate emotional processing. It is four sessions long. Delivery format takes into account stakeholder feedback, considering overall burden during acute hospitalization and the transition to outpatient care. Sessions one and two are 30 minutes and one week apart. Sessions three and four are 50 minutes long and two weeks apart. Session one must occur during hospitalization. Sessions 2-4 can be completed via video/telehealth if the patient is discharged during the treatment course.

Promotion of Emotional Disclosure for Burns (PoED-B)

mEUC is an individually-administered psychoeducation control for burn patients modeled after minimally enhanced care in acute care surgery units. In one 30-minute session, the therapist reviews with the participant a standardized psychoeducation handout on common psychological reactions after burn injury, giving them time to ask questions or express concerns within a supportive therapy framework. Then, the participant is given the handout, which also includes self-help skills. After study completion, participants will be given referrals for outpatient mental health services.

minimally Enhanced Usual Care control (mEUC)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Alert, oriented, \& not withdrawing from substance at time of screening
  • Can read and write in English
  • Hospitalized within 10 days of burn injury
  • Anticipated discharge \<=4 weeks
  • Have an email, mailing address, and at least 1 smart device for telehealth sessions
  • PTSD risk score of 2 or greater (patient-only)
  • Willing to attend therapy sessions with a loved one

You may not qualify if:

  • Currently incarcerated or in police custody
  • \> 10 days post-burn
  • Lifetime diagnosis of primary psychosis or intellectual disability
  • Ongoing reported domestic violence in the dyad
  • Unstable bipolar disorder, severe substance use disorder, or acute suicidality with imminent intent that does not remit within 10 days of burn-injury
  • Inflammation Confounds (patient-only) of BMI \> 40, metabolic syndrome, admission A1C of \>= 6.5%
  • Currently receiving couples therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Southern California, Keck School of Medicine & Los Angeles General Medical Center

Los Angeles, California, 90033, United States

Location

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticBurnsWounds and InjuriesStress Disorders, Traumatic, AcuteTrauma and Stressor Related DisordersStress Disorders, Traumatic

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Sarah Stoycos, PhD

    University of Southern California, Keck School of Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sarah Stoycos, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 3, 2026

First Posted

June 18, 2026

Study Start (Estimated)

August 1, 2026

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

February 28, 2029

Last Updated

June 18, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will share

De-identified demographic and raw quantitative data will be deposited into the NIMH Data Archive (NDA). All data will be de-identified prior to receipt by the repository. Data will be de-identified pursuant to the HIPAA Privacy Rule, 45 CFR § 164.514(b). A brief study protocol will also be submitted to NDA and will be made freely available.

Shared Documents
STUDY PROTOCOL
Time Frame
Data will be deposited starting 18 months after the award begins and will be deposited every six months thereafter following the usual NDA data submission dates. Data generated from this project will be made available as soon as possible, and no later than the time of publication or the end of the funding period, whichever comes first. The duration of preservation and sharing of the data is controlled by the NDA; NDA currently has no process for deleting or retiring datasets, and thus far no data has been removed to our knowledge.
Access Criteria
To request access to the data, researchers can use the standard processes at NDA; the NDA Data Access Committee will review requests and decide which requests to grant. The standard NDA access process allows access for one year and is renewable thereafter.

Locations